A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1)
for Overweight
55 locations incl. Chandler
Sponsor: Pfizer
Sex: All·Age: 18+
Code: NCT07575932·Phase 2·Recruiting·Listed May 2026
DM Clinical Research - Tomball
Clinical research site in Tomball, Texas · DM Clinical Research — Tomball, 13406 Medical Complex Dr #190, Tomball, TX 77375 · (346) 550-9559 · Website
Part of DM Clinical Research
As of July 2026, 18 paid clinical trials are recruiting at DM Clinical Research - Tomball in Tomball, Texas. Active studies at this site cover conditions such as Rheumatoid Arthritis, Arthritis, Psoriatic and Body Weight. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at DM Clinical Research - Tomball (18)
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
for Obesity or Overweight
34 locations incl. Guntersville
Sponsor: Hoffmann-La Roche
Sex: All·Age: 18+
Code: NCT07351058·Phase 3·Recruiting·Listed Jan 2026
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
for Clostridioides Difficile Associated Disease
135 locations incl. Athens
Sponsor: Pfizer
Sex: All·Age: 65+·Accepts healthy volunteers
Code: NCT07282665·Phase 3·Recruiting·Listed Dec 2025
A Study of Dotinurad Versus Allopurinol in Participants With Gout
for Gout
68 locations incl. Birmingham
Sponsor: Crystalys Therapeutics
Sex: All·Age: 18 - 75
Code: NCT07089875·Phase 3·Recruiting·Listed Jul 2025
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
for Tophaceous Gout
75 locations incl. Birmingham
Sponsor: Crystalys Therapeutics
Sex: All·Age: 18 - 75
Code: NCT07089888·Phase 3·Recruiting·Listed Jul 2025
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
for Rheumatoid Arthritis
56 locations incl. Peoria
Sponsor: AbbVie
Sex: All·Age: 18+
Code: NCT06972446·Phase 2·Recruiting·Listed May 2025
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
for High Risk Cardiovascular Disease
261 locations incl. Birmingham
Sponsor: Alnylam Pharmaceuticals
Sex: All·Age: 18+
Code: NCT07181109·Phase 3·Recruiting·Listed Sep 2025
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
for Migraine
29 locations incl. Hawthorne
Sponsor: Pfizer
Sex: All·Age: 6 - 17
Code: NCT05156398·Phase 3·Recruiting·Listed Dec 2021
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
for Sjögren's Syndrome
31 locations incl. Avondale
Sponsor: Amgen
Sex: All·Age: 18+
Code: NCT06747949·Phase 3·Recruiting·Listed Dec 2024
Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia
for Hypertriglyceridemia
81 locations incl. Bakersfield
Sponsor: Arrowhead Pharmaceuticals
Sex: All·Age: 18+
Code: NCT06822790·Phase 3·Recruiting·Listed Feb 2025
To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
for Chronic Obstructive Pulmonary Disease (COPD)
12 locations incl. Phoenix
Sponsor: Expedition Therapeutics, Inc
Sex: All·Age: 40 - 85
Code: NCT07684820·Phase 2·Recruiting·Listed Jul 6, 2026
A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout Participants
for Gout
17 locations incl. Granada Hills
Sponsor: Crystalys Therapeutics
Sex: All·Age: 18 - 75
Code: NCT07535034·Phase 2·Recruiting·Listed Apr 2026
A Study to Learn About mRNA Vaccines Against Influenza in Adults
for Healthy Adults
15 locations incl. Mobile
Sponsor: Pfizer
Sex: All·Age: 18+·Accepts healthy volunteers
Code: NCT07431853·Phase 2·Recruiting·Listed Feb 2026
A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)
for Active Rheumatoid Arthritis
22 locations incl. Gilbert
Sponsor: Elevara Medicines Limited
Sex: All·Age: 18 - 75
Code: NCT07409103·Phase 2·Recruiting·Listed Feb 2026
A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
for Rheumatoid Arthritis
12 locations incl. Peoria
Sponsor: Hoffmann-La Roche
Sex: All·Age: 18+
Code: NCT07137598·Phase 2·Recruiting·Listed Aug 2025
Study of GS-0151 in Participants With Rheumatoid Arthritis
for Rheumatoid Arthritis
18 locations incl. Anniston
Sponsor: Gilead Sciences
Sex: All·Age: 18 - 75
Code: NCT06902519·Phase 1·Recruiting·Listed Mar 2025
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis
for Arthritis, Psoriatic
21 locations incl. Glendale
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT06807424·Phase 3·Recruiting·Listed Feb 2025
An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis
for Rheumatoid Arthritis
1 location in Tomball
Sponsor: Hoffmann-La Roche
Sex: All·Age: 18+
Code: NCT07620392·Phase 2·Recruiting·Listed Jun 2, 2026
More research sites in Tomball
- DM Clinical Research (8 trials)
- Northwest Houston Heart Center (5 trials)
- Northwest Houston Clinical Research PLLC (3 trials)
- DM Clinical Research - Tomball - Multiple Specialties (2 trials)
- GSK Investigational Site (2 trials)
- Kailera Clinical Site (2 trials)
- DM Clinical Research - TRA (2 trials)
- Texas Gastro Consultants (2 trials)
- DM Clinical Research (Network) (1 trial)
- Horizon Clinical Research Group (1 trial)